48 results
Page 2 of 3
8-K
EX-2.1
dnep5w
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
pwh955a3rp
12 May 21
Quarterly report
4:26pm
DEF 14A
9ebecmiqh627ux a3
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
vfkwdr44
9 Apr 21
Preliminary proxy
4:16pm
424B4
j6bom
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
hhbvq vqiy27rehkg
25 Mar 21
Draft registration statement
12:00am
10-K
3u226byp
22 Mar 21
Annual report
4:22pm
8-K
EX-10.3
7jce06n
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-1.1
0dceh2d
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.1
um9u31gelja5vc3thn
23 Nov 20
Registration of securities for employees
5:06pm
424B4
m3or21t
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
EX-10.13
l6t3v1
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.24
6vcsu93oazl2t1d5fh5h
29 Oct 20
IPO registration
5:04pm